Called GA4GH Connect, it calls on the alliance's 500-plus members to develop new data sharing standards for use in major international genomic data initiatives.
Core elements of the new program include integrating genomic data into electronic medical records and the establishment of a national genome center.
After a 54 percent quarter over quarter rise in sales of the test, Rosetta's CEO said that the realigned strategy will take the firm to profit more quickly.
St. Louis-based Benson Hill will receive a grant from the NCGA, and will work with the group on breeding corn using its CropOS informatics platform.
After reporting FY2016 revenues below market expectations, Myriad discussed plans to increase sales of Prolaris, Vectra DA, EndoPredict, GeneSight, and myChoice HRD.
During an earnings call this week, the company provided an update on the progress it is making on myPath Melanoma, Prolaris, and companion diagnostics.
If it is able to implement its strategic goals, Myriad projected, it could have $1.5 billion in annual revenues by fiscal year 2020.
BD plans to launch a cell sorter for the genomics market over the next six months and to release an automated NGS library prep system in early 2016.
The report details six recommendations that are intended to position the agency to better serve the needs of the biomedical research community.
With the recent acquisition of a German sample prep firm and the launch of its next-generation sequencing service, PerkinElmer seeks to carry out its goal to "advance its offerings to the molecular diagnostics and research markets."
The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.
Kaiser Health News reports that gene therapies could cost more than a million dollars.
Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.
In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.